The Perfect Enemy | Year: 2022 | Page 629
October 1, 2025

Year: 2022

Ketosis and Rebound COVID: Keto5 Files for Patent for Its Exogenous Ketone Salt Products as an Adjunct Supplement for Licensed COVID Treatment Paxlovid, Which May Help Reduce Rebound COVID Cases